ask="24.50"
ask_size="100"
average_daily_volume="141618"
bid="N/A"
bid_size="N/A"
book_value="3.29"
change="+0.10"
change_from_200_day_moving_average="-3.86"
change_from_50_day_moving_average="0.53"
change_from_52_week_high="-11.65"
change_From_52_week_low="1.55"
change_in_percent="+1.68%"
close="6.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.54"
ebitda="-19.44M"
eps_estimate_current_year="-2.81"
eps_estimate_next_quarter="-0.90"
eps_estimate_next_year="-2.84"
ex_dividend_date="N/A"
float_shares="5820000"
high="6.05"
high_52_weeks="17.70"
last_trade_date="2/14/2017"
last_trade_price="6.05"
last_trade_size="265"
last_trade_time="4:00pm"
low="5.65"
low_52_weeks="4.50"
market_capitalization="47.29M"
moving_average_200_day="9.91"
moving_average_50_day="5.52"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.85"
open="5.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-38.95%"
percent_change_from_50_day_moving_average="+9.52%"
percent_change_from_52_week_high="-65.82%"
percent_change_from_52_week_low="+34.44%"
previous_close="5.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.81"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.40"
stock_exchange="NCM"
symbol="TRIL"
volume="96434"
weeks_range_52="4.50 - 17.70"
